MTCH stock · STRO stock

MTCH vs STRO

Match Group Inc (MTCH) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.

Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.

Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.

Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.

Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.

MTCH currently screens at market cap $8.24B and trailing P/E 13.5. STRO currently screens at market cap $470.8M.

Not investment advice. Open the MTCH and STRO stock pages for the full models.

Not investment advice.

Popular Stock Comparisons